van Houwelingen KP - Search Results

1

Risk factors, genetic predisposition and mutations in the VHL gene in sporadic renal cell carcinoma: The Netherlands Cohort Study.

Van Dijk BA, Schouten LJ, Hulsbergen-van de Kaa CA, van Houwelingen KP, Schalken JA, Kiemeney LA, Geurts van Kessel AH, Bausch-Goldbohm RA, van den Brandt PA. Van Dijk BA, et al. Among authors: van houwelingen kp. IARC Sci Publ. 2002;156:509-10. IARC Sci Publ. 2002. PMID: 12484247 No abstract available.

2

Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study.

van Houwelingen KP, van Dijk BA, Hulsbergen-van de Kaa CA, Schouten LJ, Gorissen HJ, Schalken JA, van den Brandt PA, Oosterwijk E. van Houwelingen KP, et al. BMC Cancer. 2005 Jun 2;5:57. doi: 10.1186/1471-2407-5-57. BMC Cancer. 2005. PMID: 15932632 Free PMC article.

3

Polymorphisms in genes related to activation or detoxification of carcinogens might interact with smoking to increase renal cancer risk: results from The Netherlands Cohort Study on diet and cancer.

Smits KM, Schouten LJ, van Dijk BA, van Houwelingen K, Hulsbergen-van de Kaa CA, Kiemeney LA, Goldbohm RA, Oosterwijk E, van den Brandt PA. Smits KM, et al. World J Urol. 2008 Feb;26(1):103-10. doi: 10.1007/s00345-007-0220-5. Epub 2007 Nov 3. World J Urol. 2008. PMID: 17982751

4

Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer.

Kiemeney LA, van Houwelingen KP, Bogaerts M, Witjes JA, Swinkels DW, den Heijer M, Franke B, Schalken JA, Verhaegh GW. Kiemeney LA, et al. Among authors: van houwelingen kp. Eur J Cancer. 2006 Dec;42(18):3219-27. doi: 10.1016/j.ejca.2006.05.033. Epub 2006 Aug 28. Eur J Cancer. 2006. PMID: 16934975

5

Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer.

Verhage BA, van Houwelingen K, Ruijter TE, Kiemeney LA, Schalken JA. Verhage BA, et al. Int J Cancer. 2002 Aug 20;100(6):683-5. doi: 10.1002/ijc.10541. Int J Cancer. 2002. PMID: 12209606

6

Allelic imbalance in hereditary and sporadic prostate cancer.

Verhage BA, van Houwelingen K, Ruijter TE, Kiemeney LA, Schalken JA. Verhage BA, et al. Prostate. 2003 Jan 1;54(1):50-7. doi: 10.1002/pros.10148. Prostate. 2003. PMID: 12481255

7

Alcohol dehydrogenase type 3 (ADH3) and the risk of bladder cancer.

van Dijk B, van Houwelingen KP, Witjes JA, Schalken JA, Kiemeney LA. van Dijk B, et al. Among authors: van houwelingen kp. Eur Urol. 2001 Nov;40(5):509-14. doi: 10.1159/000049827. Eur Urol. 2001. PMID: 11752857

8

Is increased CAG repeat length in the androgen receptor gene a risk factor for male subfertility?

Van Golde R, Van Houwelingen K, Kiemeney L, Kremer J, Tuerlings J, Schalken J, Meuleman E. Van Golde R, et al. J Urol. 2002 Feb;167(2 Pt 1):621-3. doi: 10.1016/S0022-5347(01)69098-0. J Urol. 2002. PMID: 11792931

9

Polymorphisms in the vitamin D receptor gene and the androgen receptor gene and the risk of benign prostatic hyperplasia.

Bousema JT, Bussemakers MJ, van Houwelingen KP, Debruyne FM, Verbeek AL, de La Rosette JJ, Kiemeney LA. Bousema JT, et al. Among authors: van houwelingen kp. Eur Urol. 2000 Feb;37(2):234-8. doi: 10.1159/000020124. Eur Urol. 2000. PMID: 10705205

10

Polymorphisms in the alpha1A-adrenoceptor gene do not modify the short- and long-term efficacy of alpha1-adrenoceptor antagonists in the treatment of benign prostatic hyperplasia.

Mochtar CA, Laan W, Van Houwelingen KP, Franke B, De La Rosette JJ, Schalken JA, Kiemeney LA. Mochtar CA, et al. Among authors: van houwelingen kp. BJU Int. 2006 Apr;97(4):852-5. doi: 10.1111/j.1464-410X.2006.05998.x. BJU Int. 2006. PMID: 16536786

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters